• MIPS 2020—What’s New With Promoting Interoperability

    Excerpted from MIPS—What’s New in 2020 for Ophthalmology (EyeNet, January 2020). Also see MIPS 2020: A Primer and Reference, which is being posted online ahead of print.


    Promoting interoperability (PI) is MIPS’ EHR-based performance category. Much about PI stays the same in 2020, including the 90-day performance period—but there have been some changes, including the following. 

    An opioid-related measure is removed. For 2020, CMS is removing the Verify Opioid Treatment Agreement measure, but it is retaining the Query of Prescription Drug Monitoring Program (PDMP) measure, which continues to be an optional measure that can earn clinicians bonus points. In a change that is retroactive to 2019, you no longer need to report a numerator and denominator for the PDMP measure; instead, report a “yes” or “no.”

    Health Information Exchange (HIE) measures. In another development that is retroactive to 2019, if you claim an exclusion for the Support Electronic Referrals Loops by Sending Health Information measure, the points for that measure will be reassigned to the Provide Patients Electronic Access to Their Health Information measure. Also retroactive to 2019, in an attempt to clean up some confusing language, CMS rewrote the exclusion description of the second HIE measure, Support Electronic Referrals Loops by Receiving and Incorporating Health Information.

    Previous: MIPS 2020—Changes to the Quality Measures

    Next: MIPS 2020—What’s New With Improvement Activities

    DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.

    COPYRIGHT© 2020, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology.®

    All of the American Academy of Ophthalmology (AAO)–developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).